4 withdrawn. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Withdrawn 4 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Exercise: new trials by email Literature Review of Exercise trials Research Report on Exercise
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate PU-AD in Subjects With Amyotrophic Lateral Sclerosis PU-AD, Placebo - Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Withdrawn | Samus Therapeutics, Inc. | 2023-01-01 | 2022-11-17 | |
| A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for Treatment of Plaque Psoriasis in Adults SAN021 Serum, SAN021 Placebo - Plaque Psoriasis | Phase 2 | Withdrawn | Santalis Pharmaceuticals, Inc. | 2018-06-10 | 2019-01-17 | |
| A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis SAN007 Cream, Placebo - Atopic Dermatitis | Phase 2 | Withdrawn | Santalis Pharmaceuticals, Inc. | 2018-06-01 | 2019-01-17 | |
| Accessing Mobility Using Wearable Sensors Exercise - COPD, Pulmonary Disease | Phase 1 / Phase 2 | Withdrawn | Baylor College of Medicine | 2018-05-21 | 2025-08-27 |
Amyotrophic Lateral Sclerosis (1) · Cardiovascular Diseases (1) · Dermatitis, Atopic (1) · Eczema (1) · Heart Failure (1) · Lung Diseases (1) · Pulmonary Disease, Chronic Obstructive (1)
Santalis Pharmaceuticals, Inc. (2) · Baylor College of Medicine (1) · Samus Therapeutics, Inc. (1)
Australia (1) · United States (1)
Bijan Najafi, PhD (1) · Michael Silverman, MD (1)